Archive - January 2023
Modus Therapeutics submits patent application for sevuparin in kidney disease
Ipsen reports positive phase 3 data for Onivyde in pancreatic cancer
Alzheimer’s Society urges UK government to deliver on dementia plan
Priothera announces first patients enrolled in pivotal MO-TRANS global Phase 2b/3 study with mocravimod as an adjunctive and maintenance therapy for patients with Acute Myeloid Leukemia (AML) undergoing allogeneic Hematopoietic Cell Transplant (HCT)
First patients enrolled for Priothera’s mocravimod trial
OxSonics trial produces positive SonoTran data
First Indian intranasal COVID-19 vaccine about to launch
FDA awards CardioRenal Systems Breakthrough Device Designation for RenalGuard Therapy